Medtronic 2012 Annual Report Download - page 34

Download and view the complete annual report

Please find page 34 of the 2012 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

division at St. Jude from 2001 to 2007, and prior positions included serving St. Jude as President of the
company’s Daig Catheter division and numerous leadership positions at Eli Lilly & Company. Mr. Coyle is
a member of the board of directors of Volcano Corporation.
H. James Dallas, age 53, has been Senior Vice President, Quality and Operations since April 2008.
Prior to that, he was Senior Vice President and Chief Information Officer of Medtronic from April 2006 to
April 2008. He was Vice President and Chief Information Officer of Georgia Pacific Corporation from
December 2002 to December 2005; General Manager of the Transportation Division and President of the
Lumber Division of Georgia Pacific Corporation from October 2001 to December 2002; and Vice President,
Building Products Distribution Sales and Logistics, Georgia Pacific Corporation from October 2000 to
October 2001. Mr. Dallas is a member of the board of directors of KeyCorp.
Gary L. Ellis, age 55, has been Senior Vice President and Chief Financial Officer since May 2005. Prior
to that, he was Vice President, Corporate Controller and Treasurer since October 1999 and Vice President
and Corporate Controller from August 1994 to October 1999. Mr. Ellis joined Medtronic in 1989 as Assistant
Corporate Controller and was promoted to Vice President of Finance for Medtronic Europe in 1992, until
being named as Corporate Controller in 1994. Mr. Ellis is a member of the board of directors of The Toro
Company and past chairman of the American Heart Association.
D. Cameron Findlay, age 52, has been Senior Vice President, General Counsel and Corporate Secretary
since August 2009. Prior to that, Mr. Findlay was Executive Vice President and General Counsel of Aon
Corporation from August 2003 to June 2009. Prior to joining Aon, Mr. Findlay served as the U.S. Deputy
Secretary of Labor. Before joining the Labor Department in June 2001, Mr. Findlay was a partner at the law
firm now known as Sidley Austin LLP. Before that, he served in the White House as an aide to U.S. President
George H. W. Bush.
Richard Kuntz, M.D., age 55, has been Senior Vice President and Chief Scientific, Clinical and
Regulatory Officer since August 2009. Prior to that, he was Senior Vice President and President,
Neuromodulation from October 2005 to August 2009; and prior to that, he was an interventional cardiologist
and Chief of the Division of Clinical Biometrics at Brigham and Women’s Hospital and Associate Professor
of Medicine and Chief Scientific Officer of the Harvard Clinical Research Institute. Mr. Kuntz is a member
of the board of directors of Tengion, Inc.
Christopher J. O’Connell, age 45, has been Executive Vice President and Group President, Restorative
Therapies Group since August 2009. Prior to that, he was Senior Vice President and President, Diabetes from
October 2006 to August 2009, President of Medtronic’s Emergency Response Systems division from May
2005 to October 2006, and Vice President of Sales and Marketing of Medtronic’s Cardiac Rhythm Disease
Management division from November 2001 to May 2005. Mr. O’Connell has served in various management
positions since joining the Company in 1994.
Caroline Stockdale, age 48, has been Senior Vice President and Chief Human Resources Officer since
April 2010. Prior to that, she served as Vice President of Revenue Cycle Operations at Accretive Health
from January 2009 to May 2010. From 2005 to 2009, she served as Executive Vice President of Global
Human Resources at Warner Music Group; from 2002 to 2005, she was Senior Vice President, Human
Resources, at American Express Financial Advisors (Ameriprise); and from 1997 to 2002, she was Executive
Vice President and Global HR Leader at GE Capital.
Item 1A. Risk Factors
Investing in Medtronic involves a variety of risks and uncertainties, known and unknown, including,
among others, those discussed below.
The medical device industry is highly competitive and we may be unable to compete effectively.
We compete in both the therapeutic and diagnostic medical markets in more than 120 countries
throughout the world. These markets are characterized by rapid change resulting from technological
advances and scientific discoveries. In the product lines in which we compete, we face a mixture of
competitors ranging from large manufacturers with multiple business lines to small manufacturers that offer
a limited selection of niche products. Development by other companies of new or improved products,
processes, or technologies may make our products or proposed products less competitive. In addition, we
17